Mclean Hospital

Addiction Related Content


McLean LEADER Provides Specialized Care for First Responders

McLean Hospital is proud to be the home of McLean LEADER (Law Enforcement, Active Duty, Emergency Responder), a program providing specialized mental health and addictions services for police, active-duty military, and other first responders. This population endures unique on-duty and personal stresses and often faces many obstacles in seeking expert help. In the aftermath of the 2013 Boston...

Autism-Related Protein Shown to Play Vital Role in Addiction

In a paper published in the latest issue of the neuroscience journal Neuron, McLean Hospital investigators report that a gene essential for normal brain development, and previously linked to autism spectrum disorders, also plays a critical role in addiction-related behaviors. “In our lab, we investigate the brain mechanisms behind drug addiction—a common and devastating disease with...

McLean Hospital’s Dr. Shelly Greenfield Selected for Prestigious National Award

McLean Hospital is pleased to announce that Chief Academic Officer Shelly Greenfield, MD, MPH, has been chosen to receive the 2014 R. Brinkley Smithers Distinguished Scientist Award from the American Society of Addiction Medicine (ASAM). Greenfield will receive the award and deliver the keynote plenary address at ASAM’s forthcoming 45th Annual Medical Scientific Conference in Orlando,...

Nancy K. Mello, Pioneer in Substance Abuse Research, Dies at 78

Nancy K. Mello, PhD, director of McLean Hospital’s Alcohol and Drug Abuse Research Center (ADARC) and professor of psychology (neuroscience) at Harvard Medical School, passed away unexpectedly on Nov. 25. She was 78. A dedicated and well-respected researcher and mentor, Dr. Mello along with her husband Jack H. Mendelson, MD, founded the ADARC at McLean Hospital nearly 40 years ago....

McLean Hospital’s Roger Weiss Earns Hazelden’s Dan Anderson Research Award

Roger D. Weiss, MD, chief of McLean Hospital’s Division of Alcohol and Drug Abuse, has been selected as the 2012 recipient of the Hazelden Foundation’s Dan Anderson Research Award. Sponsored by the Butler Center for Research at Hazelden, the Dan Anderson Research Award recognizes a single published article by a researcher who has advanced the scientific knowledge of addiction recovery...

McLean Hospital Study Finds Herbal Extract May Curb Binge Drinking

An extract of the Chinese herb kudzu dramatically reduces drinking and may be useful in the treatment of alcoholism and curbing binge drinking, according to a new study by McLean Hospital and Harvard Medical School researchers. “Our study is further evidence that components found in kudzu root can reduce alcohol consumption and do so without adverse side effects,” said David Penetar...

Abu Dhabi: Meeting the Health Care Challenges a Half a World Away

Despite distance, cultural differences, and occasional language barriers, McLean Hospital clinicians and their colleagues from the National Rehabilitation Center (NRC) in Abu Dhabi have found a common goal—to expand substance abuse treatment programs in the United Arab Emirates (UAE). Long known for developing cutting-edge programs for the research and treatment of substance abuse, McLean...

Seeing Beyond The Data: McLean-Led National Study Informs Clinical Care Methods

Chief of the Division of Alcohol and Drug Abuse, Roger D. Weiss, MD, has long been a leader in the field of substance abuse treatment, research, and education. It was no surprise when he was tapped by the National Institute of Drug Abuse (NIDA) to lead the first large-scale study to address treatment of prescription opioid addiction. The results of the six-year study, announced in the December...

Suboxone is Most Effective in Treating Painkiller Addiction

Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's online edition of the Archives of General Psychiatry (doi: 10.1001/archgenpsychiatry.2011.121). “Adjunctive Counseling During Brief and Extended Buprenorphine-...

With Humanity, Program Addresses Addiction and Underlying Illness

Psychiatrist Andrew Gill, MD, sometimes begins his group therapy sessions by modifying the traditional Alcoholics Anonymous-style introduction. He instructs his patients to say: “My name is Joe, and I’m a human being—with a substance abuse problem,” instead of the traditional: “My name is Joe and I’m an alcoholic.” It may sound like a subtle difference,...

McLean Working to Expand Substance Abuse Services in the United Arab Emirates

McLean Hospital, the largest psychiatric affiliate of Harvard Medical School and a member of Partners HealthCare, has signed a five-year contract with the National Rehabilitation Center (NRC) in Abu Dhabi to provide consultation services that will allow the NRC to offer expanded substance abuse treatment programs within the United Arab Emirates (UAE). The contract between McLean and the NRC was...

Recovery in Residence: New Program Fills Gap in Addiction Treatment in the Region

In keeping with its strategic goal of extending services, the hospital has opened the McLean Residence at the Brook, a transitional living program for adults with substance use disorders. The eight-bedroom residence, located in a newly renovated Colonial in Waltham, Massachusetts, offers a structured, supportive home-like environment. With a minimum length of stay of 90 days, the private-pay...

Making Connections: Divisions Advance McLean’s Strategic Agenda

When Bill and Barbara Boger learned of plans for a Division of Psychotic Disorders at McLean, they saw an opportunity to make a lasting difference through their philanthropy. The Bogers, McLean National Council members and longtime donors, have contributed to many clinical and research endeavors at the hospital over the years, often helping new initiatives get their start. In 2009, they saw the...

Mission Possible: Buzz Aldrin Shares His ‘Magnificent Desolation’

Astronaut Buzz Aldrin may have made it to the moon, but his journey upon returning to Earth was, by his own account, an even greater challenge. When he returned from the Apollo mission in 1969, Aldrin, the second person to walk on the moon, struggled with both the exhilaration and overwhelming public notoriety of having reached the grandest goal of his career at age 39. He plunged into depression...

Fighting the Myth of Marijuana: Clinical Investigator Addresses Marijuana Dependence

As a psychiatrist working in McLean’s Alcohol and Drug Abuse Treatment Program, Kevin Hill, MD, MHS, recognizes the reality of relapse—and the perseverance patients need to overcome their drug dependence. Every day, Hill treats individuals addicted to a range of substances and witnesses their struggles as they battle addiction. Kevin Hill, MD, MHS“Compared to other psychiatric...

Addictions 2018 Conference

McLean Hospital is pleased to offer this annual conference bringing together some of the foremost authorities in the addiction field. Topics will include new, evidence-based treatments, the nuances of treating co-occurring disorders along with addiction, and special populations. Smaller breakout sessions allow for in-depth exploration of topic areas in an interactive and stimulating format that...

Addictions 2019 Conference

McLean Hospital is pleased to offer this annual conference bringing together some of the foremost authorities in the addiction field. Topics will include new, evidence-based treatments, the nuances of treating co-occurring disorders along with addiction, and special populations. Smaller breakout sessions allow for in-depth exploration of topic areas in an interactive and stimulating format that...

Pages